Paul M. Cinciripini, PhD, on Smoking Cessation in Patients With Cancer

2017 NCCN Annual Conference

Paul M. Cinciripini, PhD, of The University of Texas MD Anderson Cancer Center, discusses the oncologist’s role in addressing and documenting cancer patients’ smoking and cessation attempts as well as treatment advances.

Elizabeth R. Plimack, MD, on Bladder Cancer: Management Updates

Elizabeth R. Plimack, MD, of Fox Chase Canc...

Pancreatic Cancer

Margaret A. Tempero, MD, on Pancreatic Cancer: Active Systemic Treatment

Margaret A. Tempero, MD, of the UCSF Helen ...

Gynecologic Cancers

ASCO Post

Christina S. Chu, MD, on HPV and Cervical/Vulvar Cancer

Christina S. Chu, MD, of Fox Chase Cancer C...

Head and Neck Cancer

David G. Pfister, MD, on HPV and Head and Neck Cancer

David G. Pfister, MD, of Memorial Sloan Ket...

Sarcoma

Suzanne George, MD, on Soft-Tissue Sarcoma: Evolving Treatment

Suzanne George, MD, of Dana-Farber Cancer I...

Jun

Today In Oncology

Paul M. Cinciripini, PhD, on Smoking Cessation in Patients With Cancer

Related Videos

Elizabeth R. Plimack, MD, on Bladder Cancer: Management Updates

Margaret A. Tempero, MD, on Pancreatic Cancer: Active Systemic Treatment

Christina S. Chu, MD, on HPV and Cervical/Vulvar Cancer

David G. Pfister, MD, on HPV and Head and Neck Cancer

Suzanne George, MD, on Soft-Tissue Sarcoma: Evolving Treatment

First-Line Atezolizumab Plus Chemotherapy vs Chemotherapy Alone in Advanced Urothelial Cancer

Cediranib/Olaparib vs Standard of Care Chemotherapy for Platinum-Sensitive Ovarian Cancer

Remote Pre- and Post-Test Genetic Counseling for Breast and Ovarian Cancer Risk

Standard vs Histology-Tailored Neoadjuvant Chemotherapy for High-Risk Soft Tissue Sarcoma

Carfilzomib vs Bortezomib in Addition to Lenalidomide/Dexamethasone in Newly Diagnosed Multiple Myeloma